Financhill
Sell
47

STRO Quote, Financials, Valuation and Earnings

Last price:
$0.86
Seasonality move :
0.48%
Day range:
$0.85 - $0.94
52-week range:
$0.52 - $5.17
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.13x
P/B ratio:
1.64x
Volume:
1.2M
Avg. volume:
2.1M
1-year change:
-78.03%
Market cap:
$77M
Revenue:
$62M
EPS (TTM):
-$2.98

Earnings Data

Next earnings date for STRO
Aug 13
2025
Most recent earnings per share
-$0.91
Missed by $0.91
(May 8/2025)
Consensus Estimate
--
(May 8/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

STRO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/13/2025 Q2 $14.5M -- -- -- --
05/08/2025 Q1 $11.6M $17.4M -$0.91 -- --
03/13/2025 Q4 $12.2M $14.8M -$0.89 -$0.96 $0.07
11/13/2024 Q3 $15.3M $8.5M -$0.59 -$0.74 $0.15
08/13/2024 Q2 $21M $25.7M -$0.59 -$0.90 $0.31
05/13/2024 Q1 $12.1M $13M -$0.95 -$1.00 $0.05
03/25/2024 Q4 $13.2M $113.7M $0.52 -$0.84 $1.36
11/13/2023 Q3 -- -- -$0.81 -$0.72 -$0.09
08/10/2023 Q2 -- -- -$0.64 -$0.69 $0.05
05/15/2023 Q1 -- -- -$0.85 -$0.75 -$0.10
03/30/2023 Q4 -- -- -$0.61 -$0.63 $0.02
11/08/2022 Q3 -- -- -$0.37 $0.01 -$0.38
08/08/2022 Q2 -- -- -$0.55 -$0.77 $0.22
05/09/2022 Q1 -- -- -$0.84 -$0.74 -$0.10
02/28/2022 Q4 -- -- -$0.83 -$0.76 -$0.07
11/10/2021 Q3 -- -- -$0.67 -$0.48 -$0.19
08/09/2021 Q2 -- -- -$0.13 -$0.40 $0.27
05/07/2021 Q1 -- -- -$0.66 -$0.60 -$0.06
03/18/2021 Q4 -- -- -$1.90 -$0.48 -$1.42
11/05/2020 Q3 -- -- $0.45 -$0.50 $0.95
08/06/2020 Q2 -- -- $0.94 -$0.57 $1.51
05/11/2020 Q1 -- -- -$0.84 -$0.57 -$0.27
03/16/2020 Q4 -- -- -$0.64 -$0.66 $0.02
11/08/2019 Q3 -- -- -$0.56 -$0.62 $0.06
08/14/2019 Q2 -- -- -$0.60 -$0.60 $0.00
04/01/2019 Q1 -- -- -$0.62 -$0.61 -$0.01
12/31/2018 Q4 -- -- -$0.07 -$0.67 $0.60
11/14/2018 Q3 -- -- -$0.43 $1.97 -$2.40

Sutro Biopharma Earnings Questions

  • How Much did Sutro Biopharma Generate in Revenue Last Quarter?

    Sutro Biopharma reported $17.4M worth of top line sales in its most recent quarter.

  • Did Sutro Biopharma Beat Earnings Last Quarter?

    Sutro Biopharma announced earnings per share of -$0.91 which represents a miss of analyst forecast a -- per share.

  • Is Sutro Biopharma Profitable?

    Sutro Biopharma reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Sutro Biopharma EPS Next Year?

    Sutro Biopharma's earnings are forecast to decrease from -$2.96 per share to -$3.07 per share next year representing a decrease of -16.22%.

  • When is Sutro Biopharma's Earnings Date?

    Sutro Biopharma's next earnings date is August 13, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Rigetti Stock Going Up?
Why Is Rigetti Stock Going Up?

Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…

How to Change Your Stock Portfolio During a Bear Market
How to Change Your Stock Portfolio During a Bear Market

The standard definition of a bear market is that one…

Why Is Newegg Commerce Up So Much?
Why Is Newegg Commerce Up So Much?

Consumer electronics eCommerce store Newegg (NASDAQ:NEGG) has staged a dramatic…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 38x

Buy
71
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
81
SMLR alert for May 19

Semler Scientific [SMLR] is up 4.97% over the past day.

Sell
25
GLOB alert for May 19

Globant SA [GLOB] is up 1.65% over the past day.

Buy
94
HIMS alert for May 19

Hims & Hers Health [HIMS] is down 4.58% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock